Martine Rothblatt
2019
In 2019, Martine Rothblatt earned a total compensation of $45.6M as Chairperson and Chief Executive Officer at United Therapeutics, a 185% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $2,643,874 |
|---|---|
| Non-Equity Incentive Plan | $1,753,125 |
| Option Awards | $40,010,000 |
| Salary | $1,218,038 |
| Other | $10,000 |
| Total | $45,635,037 |
Rothblatt received $40M in option awards, accounting for 88% of the total pay in 2019.
Rothblatt also received $2.6M of change in pension value and nonqualified deferred compensation earnings, $1.8M in non-equity incentive plan, $1.2M in salary and $10K in other compensation.
Rankings
In 2019, Martine Rothblatt's compensation ranked 15th out of 13,971 executives tracked by ExecPay. In other words, Rothblatt earned more than 99.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 15 out of 13,971 | 100th |
Division Manufacturing | 7 out of 5,692 | 100th |
Major group Chemicals And Allied Products | 1 out of 2,189 | 100th |
Industry group Drugs | 1 out of 1,875 | 100th |
Industry Pharmaceutical Preparations | 1 out of 1,387 | 100th |
Source: SEC filing on April 29, 2022.
Rothblatt's colleagues
We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2019.